|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Meerbeeck JP, Fennell DA and De
Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang S, Zimmermann S, Parikh K, Mansfield
AS and Adjei AA: Current diagnosis and management of small-cell
lung cancer. Mayo Clin Proc. 94:1599–1622. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Conen K, Hagmann R, Hess V, Zippelius A
and Rothschild SI: Incidence and predictors of bone metastases (BM)
and skeletal-related events (SREs) in small cell lung cancer
(SCLC): A swiss patient cohort. J Cancer. 7:2110–2116. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scagliotti GV, Hirsh V, Siena S, Henry DH,
Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M,
Mehta ND, et al: Overall survival improvement in patients with lung
cancer and bone metastases treated with denosumab versus zoledronic
acid: Subgroup analysis from a randomized phase 3 study. J Thorac
Oncol. 7:1823–1829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L and Gong Z: Clinical
characteristics and prognostic factors in bone metastases from lung
cancer. Med Sci Monit. 23:4087–4094. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugimoto MA, Ribeiro ALC, Costa BRC, Vago
JP, Lima KM, Carneiro FS, Ortiz MMO, Lima GLN, Carmo AAF, Rocha RM,
et al: Plasmin and Plasminogen induce macrophage reprogramming and
regulate key steps of inflammation resolution via annexin A1.
Blood. 129:2896–2907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Foo SL, Yap G, Cui J and Lim LHK:
Annexin-A1-A blessing or a curse in cancer? Trends Mol Med.
25:315–327. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo C, Liu S and Sun MZ: Potential role of
Anxa1 in cancer. Future Oncol. 9:1773–1793. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mussunoor S and Murray GI: The role of
annexins in tumour development and progression. J Pathol.
216:131–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boudhraa Z, Bouchon B, Viallard C, D'Incan
M and Degoul F: Annexin A1 localization and its relevance to
cancer. Clin Sci (Lond). 130:205–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Damazo AS, Moradi-Bidhendi N, Oliani SM
and Flower RJ: Role of annexin 1 gene expression in mouse
craniofacial bone development. Birth Defects Res A Clin Mol
Teratol. 79:524–532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan X, Liu P and Yin G: Downregulation of
annexin A1 by short hairpin RNA inhibits the osteogenic
differentiation of rat bone marrow-derived mesenchymal stem cells.
Int J Mol Med. 36:406–414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Detterbeck FC, Boffa DJ, Kim AW and Tanoue
LT: The eighth edition lung cancer stage classification. Chest.
151:193–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma N, Shen W, Pang H, Zhang N, Shi H, Wang
J and Zhang H: The effect of RCAN1 on the biological behaviors of
small cell lung cancer. Tumour Biol. 39:10104283177004052017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG; NC3Rs Reporting Guidelines Working Group, : Animal
research: Reporting in vivo experiments: The ARRIVE guidelines. Br
J Pharmacol. 160:1577–1579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miki T, Yano S, Hanibuchi M and Sone S:
Bone metastasis model with multiorgan dissemination of human
small-cell lung cancer (SBC-5) cells in natural killer
cell-depleted SCID mice. Oncol Res. 12:209–217. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mak IW, Turcotte RE and Ghert M:
Parathyroid hormone-related protein (PTHrP) modulates adhesion,
migration and invasion in bone tumor cells. Bone. 55:198–207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Frieling JS, Shay G, Izumi V, Aherne ST,
Saul RG, Budzevich M, Koomen J and Lynch CC: Matrix
metalloproteinase processing of PTHrP yields a selective regulator
of osteogenesis, PTHrP1-17. Oncogene. 36:4498–4507.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kakonen SM, Selander KS, Chirgwin JM, Yin
JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y and Guise TA:
Transforming growth factor-beta stimulates parathyroid
hormone-related protein and osteolytic metastases via Smad and
mitogen-activated protein kinase signaling pathways. J Biol Chem.
277:24571–24578. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao X, Kallakury B, Chahine JJ, Hartmann
D, Zhang Y, Chen Y, Zhang H, Zhang B, Wang C and Giaccone G:
Surgical resection of SCLC: Prognostic factors and the tumor
microenvironment. J Thorac Oncol. 14:914–923. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katakami N, Kunikane H, Takeda K, Takayama
K, Sawa T, Saito H, Harada M, Yokota S, Ando K, Saito Y, et al:
Prospective study on the incidence of bone metastasis (BM) and
skeletal-related events (SREs) in patients (pts) with stage IIIB
and IV lung cancer-CSP-HOR 13. J Thorac Oncol. 9:231–238. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sobral-Leite M, Wesseling J, Smit VT,
Nevanlinna H, van Miltenburg MH, Sanders J, Hofland I, Blows FM,
Coulson P, Patrycja G, et al: Annexin A1 expression in a pooled
breast cancer series: Association with tumor subtypes and
prognosis. BMC Med. 13:1562015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Biaoxue R, Xiling J, Shuanying Y, Wei Z,
Xiguang C, Jinsui W and Min Z: Upregulation of Hsp90-beta and
annexin A1 correlates with poor survival and lymphatic metastasis
in lung cancer patients. J Exp Clin Cancer Res. 31:702012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin Y, Lin G, Fang W, Zhu H and Chu K:
Increased expression of annexin A1 predicts poor prognosis in human
hepatocellular carcinoma and enhances cell malignant phenotype. Med
Oncol. 31:3272014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sato Y, Kumamoto K, Saito K, Okayama H,
Hayase S, Kofunato Y, Miyamoto K, Nakamura I, Ohki S, Koyama Y and
Takenoshita S: Up-regulated annexin A1 expression in
gastrointestinal cancer is associated with cancer invasion and
lymph node metastasis. Exp Ther Med. 2:239–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garcia Pedrero JM, Fernandez MP, Morgan
RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C and Rodrigo JP:
Annexin A1 down-regulation in head and neck cancer is associated
with epithelial differentiation status. Am J Pathol. 164:73–79.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rodrigo JP, Garcia-Pedrero JM, Fernandez
MP, Morgan RO, Suarez C and Herrero A: Annexin A1 expression in
nasopharyngeal carcinoma correlates with squamous differentiation.
Am J Rhinol. 19:483–487. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y,
Han YL, Chen BS, Wei F, Qian XH, et al: Three isoforms of annexin I
are preferentially expressed in normal esophageal epithelia but
down-regulated in esophageal squamous cell carcinomas. Oncogene.
21:6641–6648. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bizzarro V, Belvedere R, Migliaro V,
Romano E, Parente L and Petrella A: Hypoxia regulates ANXA1
expression to support prostate cancer cell invasion and
aggressiveness. Cell Adh Migr. 11:247–260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu JF, Huang W, Yi HM, Xiao T, Li JY,
Feng J, Yi H, Lu SS, Li XH, Lu RH, et al: Annexin A1-suppressed
autophagy promotes nasopharyngeal carcinoma cell invasion and
metastasis by PI3K/AKT signaling activation. Cell Death Dis.
9:11542018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guise TA, Mohammad KS, Clines G, Stebbins
EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L
and Chirgwin JM: Basic mechanisms responsible for osteolytic and
osteoblastic bone metastases. Clin Cancer Res. 12:6213s–6216s.
2016. View Article : Google Scholar
|
|
34
|
Roodman GD: Biology of osteoclast
activation in cancer. J Clin Oncol. 19:3562–3571. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kunihiro AG, Brickey JA, Frye JB, Luis PB,
Schneider C and Funk JL: Curcumin, but not curcumin-glucuronide,
inhibits Smad signaling in TGFβ-dependent bone metastatic breast
cancer cells and is enriched in bone compared to other tissues. J
Nutr Biochem. 63:150–156. 2019. View Article : Google Scholar : PubMed/NCBI
|
